University of California Davis Cancer Center, Division of Hematology-Oncology — Sacramento, California

University of California Davis Cancer Center, Division of Hematology-Oncology is a clinical research site located in Sacramento, California, United States 95817.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

University of California Davis Cancer Center, Division of Hematology-Oncology has participated in 1 clinical trials.

Therapeutic areas: Prostate Cancer, Hormone Refractory Prostate Cancer.

Sponsors: Agennix.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Sacramento

Browse all research sites in California · View every site in Sacramento

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California Davis Cancer Center, Division of Hematology-Oncology?

University of California Davis Cancer Center, Division of Hematology-Oncology has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California Davis Cancer Center, Division of Hematology-Oncology conducted?

University of California Davis Cancer Center, Division of Hematology-Oncology has 1 clinical trials on record. Their work covers Prostate Cancer, Hormone Refractory Prostate Cancer.

Is University of California Davis Cancer Center, Division of Hematology-Oncology accredited by Crixeo Clinical Trials?

University of California Davis Cancer Center, Division of Hematology-Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California Davis Cancer Center, Division of Hematology-Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.